Skip to main content
FDA Shortage Check

Is Ketorolac Tromethamine Injection in shortage?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

IN SHORTAGE

Ketorolac Tromethamine Injection: in shortage

Injections (vials)
A generic injection, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
  • Reason: “Delay in shipping of the drug”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Reason: “Demand increase for the drug”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Estimate: “Estimated recovery: December 2026”. Manufacturer’s estimate, Baxter Healthcare, Oct 16, 2026
DRUG
Ketorolac Tromethamine Injection
FDA LISTING
FORM
injection
STATUS
Currently in Shortage
FIRST POSTED
Mar 23, 2018
LAST FDA UPDATE
Oct 21, 2026
AS OF
Oct 24, 2026
SOURCE

FDA lists 25 presentations: 12 unavailable · 1 limited · 12 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Ketorolac Tromethamine Injection. 25 presentations from 7 makers.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Every presentation FDA lists, by maker

Availability is FDA's text for each package, as the manufacturer reported it. Makers with unavailable or limited packages come first.

Baxter Healthcare2 presentations · 1 unavailable · 1 available or not stated

Contact (FDA's listing): 888-229-0001

  • 15 mg/1 mL

    Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10)

    Estimated recovery: December 2026

    NDC 0338-0069-10Reverified

    Unavailable

  • 30 mg/1 mL

    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25)

    NDC 0338-0072-25Reverified

    Available

Fresenius Kabi USA, LLC6 presentations · 5 unavailable · 1 available or not stated

Contact (FDA's listing): 888-386-1300

  • 15 mg/1 mL

    Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10)

    Estimated recovery: TBD

    NDC 76045-107-10Reverified

    Unavailable

  • 30 mg/1 mL

    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01)

    Next release not available at this time. Check wholesalers for inventory.

    NDC 63323-162-01Reverified

    Unavailable

  • 30 mg/1 mL

    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02)

    Next release not available at this time. Check wholesalers for inventory.

    NDC 63323-162-02Reverified

    Unavailable

  • 30 mg/1 mL

    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 76045-104-10)

    Estimated recovery: TBD

    NDC 76045-104-10Reverified

    Unavailable

  • 60 mg/2 mL

    Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 76045-105-20)

    Estimated recovery: TBD

    NDC 76045-105-20Reverified

    Unavailable

  • 15 mg/1 mL

    Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 63323-161-01)

    Check wholesalers for inventory

    NDC 63323-161-01Reverified

    Available

Hikma Pharmaceuticals USA, Inc.3 presentations · 3 unavailable

Contact (FDA's listing): 800-631-2174

  • 15 mg/1 mL

    Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25)

    Estimated recovery: TBD

    NDC 0641-6041-25Reverified

    Unavailable

  • 30 mg/1 mL

    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6042-25)

    Estimated recovery: TBD

    NDC 0641-6042-25Reverified

    Unavailable

  • 30 mg/1 mL

    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6043-25)

    Estimated recovery: TBD

    NDC 0641-6043-25Reverified

    Unavailable

Hospira, Inc., a Pfizer Company3 presentations · 3 unavailable

Contact (FDA's listing): 844-646-4398

  • 15 mg/1 mL

    Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-01)

    Next Delivery and Estimated Recovery: December 2027

    NDC 0409-3793-01Revised

    Unavailable

  • 30 mg/1 mL

    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01)

    Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay

    NDC 0409-3795-01Revised

    Unavailable

  • 60 mg/2 mL (30 mg/mL)

    Ketorolac Tromethamine, Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01)

    Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay

    NDC 0409-3796-01Revised

    Unavailable

Sagent Pharmaceuticals3 presentations · 1 limited · 2 available or not stated

Contact (FDA's listing): 866-625-1618

  • 15 mg/1 mL

    Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01)

    Estimated recovery: end-October to mid-November 2026

    NDC 25021-700-01Revised

    Limited Availability

  • 30 mg/1 mL

    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01)

    NDC 25021-701-01Reverified

    Available

  • 30 mg/1 mL

    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02)

    NDC 25021-701-02Reverified

    Available

Alembic Pharmaceuticals3 presentations · 3 available or not stated

Contact (FDA's listing): 908-393-9604

  • 15 mg/1 mL

    Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 62332-599-25)

    NDC 62332-599-25Reverified

    Available

  • 30 mg/1 mL

    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 62332-600-25)

    NDC 62332-600-25Reverified

    Available

  • 60 mg/2 mL

    Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25)

    NDC 62332-601-25Reverified

    Available

Gland Pharma Limited5 presentations · 5 available or not stated

Contact (FDA's listing): 833-291-9645

  • 15 mg/1 mL

    Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01)

    NDC 25021-700-01Reverified

    Available

  • 30 mg/1 mL

    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01)

    NDC 25021-701-01Reverified

    Available

  • 30 mg/1 mL

    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02)

    NDC 25021-701-02Reverified

    Available

  • 30 mg/1 mL

    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25)

    Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.

    NDC 72266-118-25Reverified

    Available

  • 30 mg/1 mL

    Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-119-25)

    Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.

    NDC 72266-119-25Reverified

    Available

What the manufacturers told FDA

  • Baxter Healthcare · ‘Estimated recovery: December 2026’ · updated Oct 2026
  • Fresenius Kabi USA, LLC · ‘Estimated recovery: TBD’ · updated Oct 2026
  • Fresenius Kabi USA, LLC · ‘Next release not available at this time. Check wholesalers for inventory.’ · updated Oct 2026
  • Hikma Pharmaceuticals USA, Inc. · ‘Estimated recovery: TBD’ · updated Oct 2026
  • Hospira, Inc., a Pfizer Company · ‘Next Delivery and Estimated Recovery: December 2027’ · updated Oct 2026

More on FDA ↗ (opens in a new tab)

Reason for the shortage (FDASIA)

  • Delay in shipping of the drug
  • Demand increase for the drug
  • Other

As reported by the manufacturer under the Food and Drug Administration Safety and Innovation Act.

Shown as FDA status, not as suggestions.

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Ketorolac Tromethamine Injection in shortage?
Yes. As of Oct 24, 2026, FDA lists Ketorolac Tromethamine Injection as currently in shortage: 25 presentations, 12 unavailable and 1 limited.
When will the Ketorolac Tromethamine Injection shortage end?
FDA gives no end date. 11 presentations carry a manufacturer’s own estimate, quoted on this page with its date.
Does FDA list alternatives to Ketorolac Tromethamine Injection?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.